Ataxin 2 (ATXN2) Peptid
ATXN2
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle Ataxin 2 (ATXN2) Produkte
- Ataxin 2 (ATXN2)
- Protein-Typ
- Synthetic
- Spezies
- Säugetier
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequenz
- HAPMMLMTTQ PPGGPQAALA QSALQPIPVS TTAHFPYMTH PSVQAHHQQQ
- Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of ATXN2 antibody,
Alternative Names: ATXN2 control peptide, ATXN2 antibody Blocking Peptide, Anti-ATXN2 Blocking Peptide, ataxin 2 Blocking Peptide, ATX2 Blocking Peptide, FLJ46772 Blocking Peptide, SCA2 Blocking Peptide, TNRC13 Blocking Peptide, ATXN2, ATXN-2, ATXN 2, ATXN-2 Blocking Peptide, ATXN 2 Blocking Peptide
-
-
- Applikationshinweise
- Optimal conditions should be determined by the investigator
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C long term.
-
- Target
- Ataxin 2 (ATXN2)
- Synonyme
- ASL13 Peptide, ATX2 Peptide, SCA2 Peptide, TNRC13 Peptide, 9630045M23Rik Peptide, AW544490 Peptide, Sca2 Peptide, ATXN2 Peptide, MGC115230 Peptide, ataxin 2 Peptide, ataxin 2 L homeolog Peptide, ATXN2 Peptide, Atxn2 Peptide, atxn2.L Peptide
- Hintergrund
- The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA ty.
- Molekulargewicht
- 140 kDa
-
Sie sind hier:
